Multiplikator Forward P/S: Axonics (AXNX)
Axonics, Inc. is recognized as a leader in pelvic dysfunction therapy due to its innovative mini-implants. The forward P/S ratio on this GURU.Markets chart reflects revenue expectations, with the level currently sitting around 2.70. Business growth is driven by clinic partnerships and M&A transactions, while stability is guaranteed by the neutral geopolitical status of the biomedical sector.
Ringkesan rincian data analitis Axonics, Inc (AXNX)
- rega pasar lan target rega analis:
- indikator kapitalisasi bursa perusahaan:
- statistik nilai buku emiten:
- data utang lan likuiditas:
Total Utang marang Modal Axonics, Inc.|AXNX - Rasio utang jangka dawa marang ekuitas|Utang jangka cendhak marang modal Axonics, Inc.|AXNX - Gunggung utang perusahaan|Rasio utang marang kapitalisasi buku Axonics, Inc|AXNX - Utang jangka dawa perusahaan|Kewajiban jangka cendhak perusahaan Axonics|Rasio cepet axonics.com
- rincian asil keuangan lan kelipatan valuasi:
AXNX - Penghasilan resik perusahaan|Bathi sing dikarepake Axonics, Inc.|AXNX - Rasio kapitalisasi marang bathi resik|Prakiraan rega marang bathi Axonics Modulation Technologies|AXNX - Pangali PEG|Pangali EV/EBITDA Axonics, Inc|AXNX - Pendapatan operasional sadurunge ngurangi amortisasi|Bathi saben saham sajrone rolas wulan pungkasan Axonics|AXNX - Bathi saben siji saham sajrone 12 wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan axonics.com|AXNX - Wutah bathi resik saben saham ing taun iki|Prakiraan wutah bathi kanggo taun ngarep Axonics, Inc.
- indikator dodolan lan pendapatan:
Analisis fundamental perusahaan:AXNX (Axonics)
Forward P/S measures market capitalization relative to projected revenue, allowing for an assessment of the premium paid for expected business scaling. By analyzing the forward P/S of the business, an investor determines the valuation sustainability of Axonics, Inc. (AXNX), where strong pricing power in the neuromodulation niche and synergy with Boston Scientific justify a premium multiple through the expansion of global distribution channels.
Karo sapa Axonics, Inc. saingan
Rasio rega marang prakiraan pendapatan Boston Scientific Corporation BSX|EW - Multiplikator forward rega marang pendapatan|ResMed Corp - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Insulet Inc.|ZBH: Multiplikator Forward P/S|Kapitalisasi marang prakiraan pendapatan COO|ALGN (Align Technology) - Multiplikator Forward P/S|Globus Medical Inc (GMED) - Rasio kapitalisasi marang dodolan sing dikarepake|Multiplikator Forward P/S TMDX|Multiplikator forward rega marang pendapatan Alphatec Corp ATEC|Multiplikator Forward P/S AORT (Artivion, Inc.)|Multiplikator Forward P/S enovis.com ENOV|IART - Rasio rega marang prakiraan pendapatan|ESTA: Rasio rega marang prakiraan pendapatan|BBNX (Beta Bionics Corp) - Multiplikator forward rega marang pendapatan|IRADIMED Inc. - Rega forward marang dodolan|EMBC (Embecta Corp.) - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep tandemdiabetes.com TNDM|Rasio rega marang prakiraan pendapatan Axogen (AXGN)|SI-BONE Inc (SIBN) - Prakiraan rega marang pendapatan|Orthofix International - Multiplikator forward rega marang pendapatan|Multiplikator Forward P/S Bioventus Global BVS|OrthoPediatrics Inc. - Multiplikator Forward P/S|Rasio kapitalisasi marang dodolan sing dikarepake treace.com TMCI|Strata Critical Medical (SRTA) - Rasio rega marang prakiraan pendapatan|Rega mangsa ngarep marang pendapatan CARL (Carlsmed, Inc.)|Rasio rega marang prakiraan pendapatan RxSight Corp|Multiplikator forward rega marang pendapatan ClearPoint (CLPT)|Multiplikator Forward P/S STXS|STIM - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|Rasio rega marang prakiraan pendapatan Sight Sciences SGHT|OBIO: Kapitalisasi marang prakiraan pendapatan|ANIK: Multiplikator forward rega marang pendapatan|InspireMD Inc. - Rasio rega marang pendapatan sing dikarepake|ZJYL: Multiplikator Forward P/S|Vivani Medical (VANI) - Multiplikator Forward P/S|Multiplikator forward rega marang pendapatan XTNT|Kapitalisasi marang prakiraan pendapatan NMTC (NeuroOne)|Rasio rega marang prakiraan pendapatan Modular Medical (MODD)|MYO - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|Rasio rega marang prakiraan pendapatan Envoy Medical, Inc. COCH|VVOS: Kapitalisasi marang prakiraan pendapatan|enVVeno Medical Corp. - Multiplikator Forward P/S|Rasio kapitalisasi marang dodolan sing dikarepake Sintx Technologies SINT|TNON: Multiplikator Forward P/S|Multiplikator forward rega marang pendapatan Lifeward Ltd.|Rasio rega marang prakiraan pendapatan Autonomix Medical Inc.|invobioscience.com (IVF) - Rasio kapitalisasi marang dodolan sing dikarepake|Multiplikator forward rega marang pendapatan BBLG (Bone Biologics Corp)|BIOL (BIOLASE Inc.) - Rega forward marang dodolan|Multiplikator Forward P/S DYNT (Dynatronics)|Rasio kapitalisasi marang dodolan sing dikarepake Paragon 28 Inc. (FNA)|INVO - Rasio rega marang prakiraan pendapatan
